goBalto, a provider of clinical study start-up solutions, has opened its first international locations, in Singapore and the U.K.

This expansion marks goBalto's growth into a global services organization and establishes its foothold in Asia, a biotech center and area of substantial market demand. Scaling to support global clients, goBalto is moving quickly to build a team in its Singapore office, having recently filled several key roles. goBalto also currently is hiring in the U. K. to grow its customer success division.

The new Singapore team represents combined experience in clinical trial planning and development, systems engineering and strategic client relationship management across Asia, the Middle East, South Africa, Australia and New Zealand. Previous companies for which the new team members have worked include Novartis, Takeda Global R&D Center, Anidan Group, Singapore Computer Systems, CapitaLand (one of Asia's largest real estate companies), Research in Motion, Hewlett-Packard and LinkedIn.

"Our expansion into Asia-Pac establishes us as the only study start-up solution provider with a true international presence," said Sujay Jadhav, gBalto's CEO.